King of Pessinus, a city of Phrygia, Midas he was and everything he touched turned to gold. What then do you call the individual who accounts for nearly $4B in shareholder value creation in less than one-year? …King Freytag is he!
So how does one follow-up with directing Myogen’s November 2006 $2.5B exit to Gilead (NASDAQ: GILD)? Simple…with Aspreva’s (NASDAQ: ASPV) $915MM exit to the Galencia Group (SWX: GALN) in October 2007.
Not to sound like a broken record but…Congratulations Dr. Freytag! The deal is slated to close on 3 January 2008. What a coup it would be for Colorado to attract Dr. Freytag back to the region! A boy could dream…
If you enjoyed this post get free email updates (here).